Anton Hellberg | Nutritional Science | Innovative Research Award

Innovative Research Award

Anton Hellberg
Karolinska Institutet, Sweden
Anton Hellberg
Affiliation Karolinska Institutet
Country Sweden
Scopus ID 57246107700
Documents 4
Citations 22
h-index 3
Subject Area Nutritional Science and Functional Foods
Event International Food Scientist Awards
ORCID 0000-0001-6274-8354

Anton Hellberg is a researcher affiliated with Karolinska Institutet, Sweden, whose scholarly work focuses on nutritional science, metabolic health, functional foods, and dietary interventions associated with cardiometabolic disease prevention. His published studies investigate dietary strategies such as intermittent fasting, weight regulation, insulin sensitivity, adipose tissue biology, and cardiovascular risk factors, contributing to the evidence base for personalized nutrition and preventive medicine.[1] [2]

Abstract

Anton Hellberg’s scientific portfolio centers on nutritional interventions aimed at improving metabolic health and reducing chronic disease risk. His publications evaluate intermittent fasting, weight regulation, adipose tissue biology, and biomarkers related to insulin secretion, insulin sensitivity, and cardiovascular disease. Through controlled clinical investigations, his work contributes to understanding dietary approaches capable of supporting evidence-based nutrition and preventive healthcare.[2][3]

Keywords

Nutritional Science, Functional Foods, Intermittent Fasting, Type 2 Diabetes, Cardiovascular Disease, Metabolic Health, Weight Management, Insulin Sensitivity

Introduction

Modern nutritional science increasingly emphasizes dietary interventions capable of preventing chronic diseases while improving metabolic health. Anton Hellberg’s research aligns with this objective by examining structured dietary strategies, particularly intermittent fasting protocols, and their physiological effects among individuals with and without metabolic disorders. His work provides clinically relevant evidence supporting nutritional approaches to disease prevention and health promotion.[2]

Research Profile

According to available bibliometric information, Anton Hellberg has authored four indexed scholarly publications with twenty-two citations and an h-index of three. His research spans nutritional science, obesity, diabetes, cardiovascular risk reduction, adipose tissue physiology, and functional dietary interventions. These studies demonstrate interdisciplinary collaboration between clinical nutrition, molecular biology, and preventive medicine.[1]

Research Contributions

  • Clinical evaluation of the 5:2 intermittent fasting diet for metabolic health improvement.
  • Investigation of cardiovascular disease risk markers following dietary intervention.
  • Research on insulin secretion and insulin sensitivity in subjects with and without type 2 diabetes.
  • Studies exploring adipose tissue gene expression associated with weight changes.
  • Contributions supporting evidence-based nutritional strategies for chronic disease prevention.

Publications

  1. The 5:2 Diet Reduces Risk Factors for Cardiovascular Disease in Subjects with and Without Type 2 Diabetes—A Non-Randomized Controlled Trial.
    International Journal of Molecular Sciences (2026). DOI:
    10.3390/ijms27146460
  2. Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome.
    International Journal of Molecular Sciences (2024). DOI:
    10.3390/ijms252111566
  3. The 5:2 Diet Affects Markers of Insulin Secretion and Sensitivity in Subjects with and without Type 2 Diabetes—A Non-Randomized Controlled Trial.
    International Journal of Molecular Sciences (2024). DOI:
    10.3390/ijms25179731

Research Impact

The available publication record indicates growing contributions within nutritional science and functional food research. By investigating the physiological effects of dietary interventions in both healthy participants and individuals with metabolic disorders, these studies support improved understanding of nutrition-based disease prevention and clinical management strategies. The combination of clinical evidence and molecular investigations enhances the translational value of this research.[2][4]

Award Suitability

Anton Hellberg’s scholarly activities demonstrate consistent contributions to nutritional science, functional foods, and metabolic health research. His investigations into dietary interventions, cardiovascular risk factors, insulin regulation, and obesity-related mechanisms align well with the objectives of the International Food Scientist Awards, particularly recognizing research that advances evidence-based nutrition and public health.[1][3]

Conclusion

Anton Hellberg has established a focused research profile within nutritional science through investigations of dietary interventions, metabolic regulation, and cardiovascular health. His publications contribute clinically relevant evidence regarding intermittent fasting and functional nutrition, supporting future advances in personalized nutrition and preventive healthcare. These achievements provide a strong academic foundation for recognition within international food science awards programs.

References

  1. Elsevier. (n.d.). Scopus author details: Anton Hellberg, Author ID 57246107700. Scopus.
    https://www.scopus.com/pages/authors/57246107700
  2. Hellberg A., et al. (2026). The 5:2 Diet Reduces Risk Factors for Cardiovascular Disease in Subjects with and Without Type 2 Diabetes—A Non-Randomized Controlled Trial. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms27146460
  3. Hellberg A., et al. (2024). The 5:2 Diet Affects Markers of Insulin Secretion and Sensitivity in Subjects with and without Type 2 Diabetes—A Non-Randomized Controlled Trial. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms25179731
  4. Hellberg A., et al. (2024). Weight Changes Are Linked to Adipose Tissue Genes in Overweight Women with Polycystic Ovary Syndrome. International Journal of Molecular Sciences.  DOI: https://doi.org/10.3390/ijms252111566

Vikram Kumar | Nutraceuticals | Best Researcher Award

Best Researcher Award

Vikram Kumar
Affiliation Amity University Rajasthan
Country India
Scopus ID 57188881962
Documents 45
Citations 420
h-index 10
Subject Area Functional Ingredients and Nutraceuticals
Event International Food Scientist Awards
ORCID 0000-0002-9994-8904

Vikram Kumar
Amity University Rajasthan, India

Vikram Kumar is an Indian pharmaceutical scientist, academic researcher, educator, and doctoral supervisor serving as Associate Professor and PhD Coordinator at Amity Institute of Pharmacy, Amity University Rajasthan, Jaipur. With over sixteen years of teaching, research, and academic administration experience, he has contributed extensively to pharmacology, nanotechnology-based drug delivery systems, herbal therapeutics, cancer research, and pharmaceutical education. His scholarly output includes peer-reviewed publications, patents, book chapters, funded research projects, doctoral supervision, and editorial responsibilities in national and international scientific journals.[1]

Abstract

This academic profile presents the scholarly achievements, research contributions, academic leadership, and professional impact of Dr. Vikram Kumar. His work spans pharmaceutical sciences, pharmacology, herbal medicine, nanomedicine, cancer biology, neuropharmacology, and pharmaceutical education. Through publications, patents, funded projects, doctoral supervision, editorial service, and institutional leadership, he has contributed to both scientific advancement and academic capacity building within higher education institutions.[1]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Nanotechnology, Herbal Medicine, Cancer Research, Pharmaceutical Education, Pharmacogenomics, Neuroprotection, Academic Leadership.

Introduction

Vikram Kumar completed his Bachelor of Pharmacy, Master of Pharmacy in Pharmacology, and Doctor of Philosophy in Pharmacology. His academic career includes appointments at Sri Balaji College of Pharmacy, Bahra University, and Amity University Rajasthan. Throughout his professional journey, he has combined teaching excellence with active research engagement and academic administration responsibilities. His multidisciplinary expertise has enabled collaborations across pharmaceutical sciences, biotechnology, and translational research domains.[1]

Research Profile

  • Associate Professor and PhD Coordinator, Amity Institute of Pharmacy.
  • Scopus Author ID: 57188881962.
  • ORCID: 0000-0002-9994-8904.
  • Approximate cumulative journal impact factor exceeding 122.
  • Reviewer and editorial board member for several international journals.
  • Principal investigator and collaborator in government-funded research projects.

Research Contributions

Kumar’s research portfolio encompasses nanostructured lipid carriers, nanoemulsion-based therapeutics, herbal formulations, pharmacogenomics, antimicrobial technologies, anti-inflammatory agents, neuroprotective interventions, and breast cancer therapeutics. His funded projects supported by the Department of Science and Technology, Government of Rajasthan, focused on antimicrobial nanotechnology and silver nanoparticle synthesis using plant-derived materials.[2]

Publications

Kumar has authored and co-authored research articles, books, and book chapters in reputable scientific outlets. Representative contributions include investigations into anti-inflammatory activity, anti-nociceptive pharmacology, pharmacogenomics, breast cancer susceptibility, nanoplastic toxicity, and emerging therapeutic technologies.[4]

  • 72+ peer-reviewed research publications.
  • 4 published book chapters with international publishers.
  • Author of a pharmacology textbook.
  • 17 first-author publications.
  • 31 corresponding-author publications.

Research Impact

The impact of Kumar’s work is reflected through scientific publications, citation metrics, funded projects, doctoral mentorship, and intellectual property achievements. His research has contributed to contemporary discussions in pharmaceutical technology, targeted drug delivery, phytomedicine, and biomedical innovation. The grant of international and national patents further illustrates the translational relevance of his scientific activities.[5]

Award Suitability

Based on documented evidence of scholarly productivity, research leadership, academic administration, intellectual property generation, doctoral supervision, professional memberships, and sustained contributions to pharmaceutical sciences, Dr. Vikram Kumar demonstrates attributes commonly associated with recipients of academic research excellence recognitions. His interdisciplinary research profile and continued engagement in innovation-oriented pharmaceutical research support consideration for an Outstanding Researcher Award.[5]

Conclusion

Vikram Kumar has established a comprehensive academic and research profile characterized by sustained contributions to pharmacology, pharmaceutical sciences, research mentoring, innovation, and higher education leadership. His scholarly achievements, patents, publications, funded projects, and doctoral supervision collectively illustrate a notable commitment to advancing scientific knowledge and academic excellence.

References

  1. Amity University Rajasthan. (2026). Faculty Profile: Dr. Vikram Kumar, Associate Professor, Amity Institute of Pharmacy.
  2. ORCID. (2026). ORCID Record: Dr. Vikram Kumar (ORCID: 0000-0002-9994-8904).
    https://orcid.org/0000-0002-9994-8904
  3. Google Scholar. (2026). Google Scholar Profile of Dr. Vikram Kumar.
    https://scholar.google.com/citations?user=OJX4BywAAAAJ&hl=en
  4. Elsevier Scopus. (2026). Scopus Author Profile: Dr. Vikram Kumar, Author ID 57188881962.
    https://www.scopus.com/authid/detail.uri?authorId=57188881962
  5. Springer Nature. (2021). Impact of MicroRNA Polymorphisms on Breast Cancer Susceptibility.
    DOI: https://doi.org/10.1007/978-981-33-6699-